Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 30, 2010

Premium

Mersana Therapeutics, which is developing its proprietary Fleximer polymer technology for siRNA delivery, has appointed board member Nicholas Bacopoulos as its president and CEO.

Bacopoulos previously served as president and CEO of Aton Pharma, which was acquired by Merck. Before that, he was president and head of research and development at OSI Pharmaceuticals.

He has a BA from Cornell College and a PhD from the University of Iowa.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.